106 related articles for article (PubMed ID: 12595316)
21. Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein.
Aron JL; Parthun MR; Marcucci G; Kitada S; Mone AP; Davis ME; Shen T; Murphy T; Wickham J; Kanakry C; Lucas DM; Reed JC; Grever MR; Byrd JC
Blood; 2003 Jul; 102(2):652-8. PubMed ID: 12649137
[TBL] [Abstract][Full Text] [Related]
22. The histone deacetylase inhibitor MGCD0103 induces apoptosis in B-cell chronic lymphocytic leukemia cells through a mitochondria-mediated caspase activation cascade.
El-Khoury V; Moussay E; Janji B; Palissot V; Aouali N; Brons NH; Van Moer K; Pierson S; Van Dyck E; Berchem G
Mol Cancer Ther; 2010 May; 9(5):1349-60. PubMed ID: 20406947
[TBL] [Abstract][Full Text] [Related]
23. The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro.
Pepper C; Thomas A; Hoy T; Milligan D; Bentley P; Fegan C
Blood; 2003 Apr; 101(7):2454-60. PubMed ID: 12446453
[TBL] [Abstract][Full Text] [Related]
24. The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs.
Paulus A; Masood A; Miller KC; Khan AN; Akhtar D; Advani P; Foran J; Rivera C; Roy V; Colon-Otero G; Chitta K; Chanan-Khan A
Br J Haematol; 2014 Apr; 165(1):78-88. PubMed ID: 24467634
[TBL] [Abstract][Full Text] [Related]
25. Spicamycin and KRN5500 induce apoptosis in myeloid and lymphoid cell lines with down-regulation of bcl-2 expression and modulation of promyelocytic leukemia protein.
Zhang WJ; Ohnishi K; Yoshida H; Pan L; Maksumova L; Muratkhodjaev F; Luo JM; Shigeno K; Fujisawa S; Naito K; Nakamura S; Shinjo K; Takeshita A; Ohno R
Jpn J Cancer Res; 2000 Jun; 91(6):604-11. PubMed ID: 10874212
[TBL] [Abstract][Full Text] [Related]
26. Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells.
Balakrishnan K; Burger JA; Quiroga MP; Henneberg M; Ayres ML; Wierda WG; Gandhi V
Blood; 2010 Aug; 116(7):1083-91. PubMed ID: 20442367
[TBL] [Abstract][Full Text] [Related]
27. 2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells.
Steele AJ; Prentice AG; Hoffbrand AV; Yogashangary BC; Hart SM; Lowdell MW; Samuel ER; North JM; Nacheva EP; Chanalaris A; Kottaridis P; Cwynarski K; Wickremasinghe RG
Blood; 2009 Aug; 114(6):1217-25. PubMed ID: 19515722
[TBL] [Abstract][Full Text] [Related]
28. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.
Sanhes L; Tang R; Delmer A; DeCaprio JA; Ajchenbaum-Cymbalista F
Leukemia; 2003 Jun; 17(6):1104-11. PubMed ID: 12764376
[TBL] [Abstract][Full Text] [Related]
29. AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-kappaB survival pathway.
Escobar-Díaz E; López-Martín EM; Hernández del Cerro M; Puig-Kroger A; Soto-Cerrato V; Montaner B; Giralt E; García-Marco JA; Pérez-Tomás R; Garcia-Pardo A
Leukemia; 2005 Apr; 19(4):572-9. PubMed ID: 15744353
[TBL] [Abstract][Full Text] [Related]
30. ZGDHu-1 promotes apoptosis of chronic lymphocytic leukemia cells.
Qiu LN; Zhou YL; Wang ZN; Huang Q; Hu WX
Int J Oncol; 2012 Aug; 41(2):533-40. PubMed ID: 22581170
[TBL] [Abstract][Full Text] [Related]
31. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia.
McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M
Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055
[TBL] [Abstract][Full Text] [Related]
32. In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia.
Schwänen C; Hecker T; Hübinger G; Wölfle M; Rittgen W; Bergmann L; Karakas T
Leukemia; 2002 Oct; 16(10):2096-105. PubMed ID: 12357363
[TBL] [Abstract][Full Text] [Related]
33. Bortezomib induces different apoptotic rates in B-CLL cells according to IgVH and BCL-6 mutations.
Jantus-Lewintre E; Sarsotti E; Terol MJ; Benet I; García-Conde J
Clin Transl Oncol; 2006 Nov; 8(11):805-11. PubMed ID: 17134969
[TBL] [Abstract][Full Text] [Related]
34. Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemia.
Waselenko JK; Grever MR; Shinn CA; Flinn IW; Byrd JC
Leuk Res; 2001 Jun; 25(6):435-40. PubMed ID: 11337014
[TBL] [Abstract][Full Text] [Related]
35. UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism.
Byrd JC; Shinn C; Willis CR; Flinn IW; Lehman T; Sausville E; Lucas D; Grever MR
Exp Hematol; 2001 Jun; 29(6):703-8. PubMed ID: 11378265
[TBL] [Abstract][Full Text] [Related]
36. Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia.
Quiney C; Billard C; Faussat AM; Salanoubat C; Ensaf A; Naït-Si Y; Fourneron JD; Kolb JP
Leukemia; 2006 Mar; 20(3):491-7. PubMed ID: 16424868
[TBL] [Abstract][Full Text] [Related]
37. Pro-apoptotic effect of an anti-CD37 scFv-Fc fusion protein, in combination with the anti-CD20 antibody, ofatumumab, on tumour cells from B-cell malignancies.
Smolewski P; Robak P; Cebula-Obrzut B; Misiewicz M; Mędra A; Majchrzak A; Witkowska M; Stromatt S; Robak T
Eur J Cancer; 2014 Oct; 50(15):2677-84. PubMed ID: 25154027
[TBL] [Abstract][Full Text] [Related]
38. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
Campàs C; Cosialls AM; Barragán M; Iglesias-Serret D; Santidrián AF; Coll-Mulet L; de Frias M; Domingo A; Pons G; Gil J
Exp Hematol; 2006 Dec; 34(12):1663-9. PubMed ID: 17157163
[TBL] [Abstract][Full Text] [Related]
39. The triterpenoid CDDO induces apoptosis in refractory CLL B cells.
Pedersen IM; Kitada S; Schimmer A; Kim Y; Zapata JM; Charboneau L; Rassenti L; Andreeff M; Bennett F; Sporn MB; Liotta LD; Kipps TJ; Reed JC
Blood; 2002 Oct; 100(8):2965-72. PubMed ID: 12351409
[TBL] [Abstract][Full Text] [Related]
40. Proapoptotic activity of alemtuzumab alone and in combination with rituximab or purine nucleoside analogues in chronic lymphocytic leukemia cells.
Smolewski P; Szmigielska-Kaplon A; Cebula B; Jamroziak K; Rogalinska M; Kilianska Z; Robak T
Leuk Lymphoma; 2005 Jan; 46(1):87-100. PubMed ID: 15621786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
